Cerity Partners LLC Has $2.72 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cerity Partners LLC boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 177.8% during the 1st quarter, Holdings Channel reports. The institutional investor owned 182,195 shares of the medical instruments supplier’s stock after purchasing an additional 116,607 shares during the quarter. Cerity Partners LLC’s holdings in DENTSPLY SIRONA were worth $2,722,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $25,000. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 1,568 shares during the period. True Wealth Design LLC lifted its stake in shares of DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 1,950 shares during the period. Finally, Allworth Financial LP lifted its stake in shares of DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier’s stock valued at $54,000 after purchasing an additional 2,517 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on XRAY shares. Barrington Research increased their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Monday, May 12th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Finally, Wall Street Zen upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Sunday, July 13th. Ten analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus target price of $19.60.

Check Out Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

XRAY stock opened at $15.68 on Friday. The stock has a 50-day moving average price of $16.07 and a two-hundred day moving average price of $16.29. The stock has a market cap of $3.12 billion, a PE ratio of -3.45, a price-to-earnings-growth ratio of 1.13 and a beta of 0.94. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to analysts’ expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The company’s revenue was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.42 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.10%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.